Salili, Kendrick .

HRN: 26-22-56  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2025
MUPIROCIN 2%, 15G (TUBE)
05/13/2025
05/19/2025
TOPICAL
2%
BID
Folliculitis
Waiting Final Action 
05/14/2025
CEFUROXIME 750MG (VIAL)
05/14/2025
05/20/2025
IV
200mg
Q8
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: